Statement of Beneficial Ownership (sc 13d)

Date : 01/02/2020 @ 10:25PM
Source : Edgar (US Regulatory)
Stock : AquaVenture Holdings Limited (WAAS)
Quote : 27.03  -0.03 (-0.11%) @ 8:54PM
AquaVenture share price Chart
After Hours
Last Trade
Last $ 27.03 ◊ 0.00 (0.00%)

Statement of Beneficial Ownership (sc 13d)

 

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

 

 

 

SCHEDULE 13D

 

 

Under the Securities Exchange Act of 1934

AquaVenture Holdings Limited

(Name of Issuer)

 

Ordinary Shares, no par value

(Title of Class of Securities)

 

G0443N107

(CUSIP Number)

 

Copies to:

John Griffith

Vice President and General Counsel

Culligan International Company

9399 W. Higgins Rd, Ste 1100

Rosemont, IL 60018

 

and

 

James Westra

Managing Partner and Chief Legal Officer

Advent International Corporation

Prudential Tower

800 Boylston Street

Boston, MA 02199-8069

 

Copy to:

James R. Griffin

Weil, Gotshal & Manges LLP

200 Crescent Court, Suite 300

Dallas, TX 75201

Telephone: (214) 746-7779

 

Ramona Nee

Weil, Gotshal & Manges LLP

100 Federal Street, 34th Floor

Boston, Massachusetts 02110

Telephone: (617) 772-8300

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

December 23, 2019

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because § 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g) check the following box o.

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7(b) for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL CORPORATION

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
DELAWARE

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
11,269,104
(1)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
11,269,104
(1)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
35.5%
(1)

 

 

14

Type of Reporting Person
CO

 


(1)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International Corporation is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

2


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII, LLC

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
DELAWARE

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
11,269,104
(2)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
11,269,104
(2)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
35.5%
(2)

 

 

14

Type of Reporting Person
OO

 


(2)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII, LLC is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

3


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
GPE VIII GP S.À R.L.

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
LUXEMBOURG

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
7,872,596
(3)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
7,872,596
(3)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
24.8%
(3)

 

 

14

Type of Reporting Person
OO

 


(3)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that GPE VIII GP S.à r.l. is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

4


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
AP GPE VIII GP LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
DELAWARE

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
469,922
(4)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
469,922
(4)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
1.5%
(4)

 

 

14

Type of Reporting Person
PN

 


(4)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that AP GPE VIII GP Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

5


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
GPE VIII GP LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
CAYMAN ISLANDS

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
2,926,586
(5)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
2,926,586
(5)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
9.2%
(5)

 

 

14

Type of Reporting Person
PN

 


(5)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that GPE VIII GP Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

6


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
LUXEMBOURG

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
614,166
(6)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
614,166
(6)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
1.9%
(6)

 

 

14

Type of Reporting Person
PN

 


(6)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

7


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-B-1 LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
LUXEMBOURG

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
753,903
(7)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
753,903
(7)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
2.4%
(7)

 

 

14

Type of Reporting Person
PN

 


(7)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-B-1 Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

8


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-B-2 LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
LUXEMBOURG

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
562,328
(8)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
562,328
(8)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
1.8%
(8)

 

 

14

Type of Reporting Person
PN

 


(8)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-B-2 Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

9


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-B-3 LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
LUXEMBOURG

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
877,863
(9)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
877,863
(9)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
2.8%
(9)

 

 

14

Type of Reporting Person
PN

 


(9)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-B-3 Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

10


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-B LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
LUXEMBOURG

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
2,124,226
(10)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
2,124,226
(10)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
6.7%
(10)

 

 

14

Type of Reporting Person
PN

 


(10)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-B Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

11


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-C LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
LUXEMBOURG

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
345,961
(11)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
345,961
(11)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
1.1%
(11)

 

 

14

Type of Reporting Person
PN

 


(11)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-C Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

12


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-D LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
LUXEMBOURG

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
296,377
(12)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
296,377
(12)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
0.9%
(12)

 

 

14

Type of Reporting Person
PN

 


(12)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-D Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

13


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-F LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
LUXEMBOURG

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
87,899
(13)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
87,899
(13)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
0.3%
(13)

 

 

14

Type of Reporting Person
PN

 


(13)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-F Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

14


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-H LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
LUXEMBOURG

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
777,568
(14)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
777,568
(14)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
2.4%
(14)

 

 

14

Type of Reporting Person
PN

 


(14)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-H Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

15


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-I LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
LUXEMBOURG

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
722,350
(15)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
722,350
(15)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
2.3%
(15)

 

 

14

Type of Reporting Person
PN

 


(15)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-I Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

16


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-J LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
LUXEMBOURG

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
709,954
(16)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
709,954
(16)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
2.2%
(16)

 

 

14

Type of Reporting Person
PN

 


(16)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-J Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

17


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT PARTNERS GPE VIII-A LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
DELAWARE

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
30,427
(17)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
30,427
(17)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
0.1%
(17)

 

 

14

Type of Reporting Person
PN

 


(17)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent Partners GPE VIII-A Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

18


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT PARTNERS GPE VIII-B CAYMAN LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
CAYMAN ISLANDS

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
253,555
(18)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
253,555
(18)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
0.8%
(18)

 

 

14

Type of Reporting Person
PN

 


(18)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent Partners GPE VIII-B Cayman Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

19


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT PARTNERS GPE VIII CAYMAN LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
CAYMAN ISLANDS

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
141,991
(19)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
141,991
(19)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
0.4%
(19)

 

 

14

Type of Reporting Person
PN

 


(19)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent Partners GPE VIII Cayman Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

20


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT PARTNERS GPE VIII-A CAYMAN LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
CAYMAN ISLANDS

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
19,157
(20)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
19,157
(20)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
0.1%
(20)

 

 

14

Type of Reporting Person
PN

 


(20)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent Partners GPE VIII-A Cayman Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

21


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT PARTNERS GPE VIII LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
DELAWARE

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
24,792
(21)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
24,792
(21)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
0.1%
(21)

 

 

14

Type of Reporting Person
PN

 


(21)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent Partners GPE VIII Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

22


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-A LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
CAYMAN ISLANDS

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
1,440,191
(22)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
1,440,191
(22)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
4.5%
(22)

 

 

14

Type of Reporting Person
PN

 


(22)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-A Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

23


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-E LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
CAYMAN ISLANDS

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
330,185
(23)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
330,185
(23)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
1.0%
(23)

 

 

14

Type of Reporting Person
PN

 


(23)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-E Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

24


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-G LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
CAYMAN ISLANDS

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
558,948
(24)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
558,948
(24)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
1.8%
(24)

 

 

14

Type of Reporting Person
PN

 


(24)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-G Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

25


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-K LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
CAYMAN ISLANDS

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
294,124
(25)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
294,124
(25)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
0.9%
(25)

 

 

14

Type of Reporting Person
PN

 


(25)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-K Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

26


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
ADVENT INTERNATIONAL GPE VIII-L LIMITED PARTNERSHIP

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
CAYMAN ISLANDS

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
303,139
(26)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
303,139
(26)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
1.0%
(26)

 

 

14

Type of Reporting Person
PN

 


(26)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Advent International GPE VIII-L Limited Partnership is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

27


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
CULLIGAN INTERNATIONAL COMPANY

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
DELAWARE

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
11,269,104
(27)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
11,269,104
(27)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
35.5%
(27)

 

 

14

Type of Reporting Person
CO

 


(27)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Culligan is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

28


 

CUSIP No.  G0443N107

13D

 

 

 

1

Names of Reporting Persons
AMBERJACK MERGER SUB LIMITED

 

 

2

Check the Appropriate Box if a Member of a Group

 

 

(a)

 o

 

 

(b)

 x

 

 

3

SEC Use Only

 

 

4

Source of Funds
N/A

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Item 2(d) or 2(e):     o

 

 

6

Citizenship or Place of Organization
BRITISH VIRGIN ISLANDS

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With:

7

Sole Voting Power
0

 

8

Shared Voting Power
11,269,104
(28)

 

9

Sole Dispositive Power
0

 

10

Shared Dispositive Power
0

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person
11,269,104
(28)

 

 

12

Check if the Aggregate Amount in Row (11) Excludes Certain Shares   x

 

 

13

Percent of Class Represented by Amount in Row (11)
35.5%
(28)

 

 

14

Type of Reporting Person
N/A

 


(28)

An aggregate of 11,269,104 ordinary shares of AquaVenture Holdings Limited (the “Issuer”) are subject to Voting Agreements (the “Voting Agreements”), each dated as of December 23, 2019, by and between Culligan International Company (“Culligan”), on the one hand, and each of Douglas Brown and Element Partners (each, a “Stockholder” discussed in Items 3 and 4 below) representing shares beneficially owned by the Stockholders which were entered into in connection with the Agreement and Plan of Merger, dated as of December 23, 2019, by and among Culligan, Amberjack Merger Sub Limited (“Merger Subsidiary”) and the Issuer. The filing of this Schedule 13D shall not be construed as an admission that Merger Subsidiary is, for purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any ordinary shares of the Issuer held by the Stockholders. Based on the number of ordinary shares of the Issuer outstanding as of November 4, 2019, the aggregate number of ordinary shares of the Issuer covered by the Voting Agreements and held by the Stockholders represents approximately 35.5% of the outstanding ordinary shares of the Issuer.

 

29


 

Item 1.

Security and Issuer

 

This statement relates to the ordinary shares, no par value (the “Shares”), issued by AquaVenture Holdings Limited (the “Issuer”). The address of the principal executive offices of the Issuer is c/o Conyers Corporate Services (BVI) Limited, Commerce House, Wickhams Cay 1, P.O. Box 3140 Road Town, British Virgin Islands VG11110.

 

Item 2.

Identity and Background

 

This statement is being filed pursuant to Rule 13d-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), by the following entities (collectively, the “Reporting Persons” and each individually a “Reporting Person”):

 

1.              Advent International Corporation, a Delaware corporation (“Advent”);

 

2.              Advent International GPE VIII, LLC, a Delaware limited liability company (“Advent Top GP”);

 

3.              GPE VIII GP s.à r.l., a société à responsabilité limitée organized under the laws of Luxembourg (“Advent GP Luxembourg”);

 

4.              AP GPE VIII GP Limited Partnership, a Delaware limited partnership (“Advent GP AP”);

 

5.              GPE VIII GP Limited Partnership, a limited partnership organized under the laws of the Cayman Islands (“Advent GP Cayman”);

 

6.              Advent International GPE VIII Limited Partnership, a limited partnership organized under the laws of Luxembourg;

 

7.              Advent International GPE VIII-B-1 Limited Partnership, a limited partnership organized under the laws of Luxembourg;

 

30


 

8.              Advent International GPE VIII-B-2 Limited Partnership, a limited partnership organized under the laws of Luxembourg;

 

9.              Advent International GPE VIII-B-3 Limited Partnership, a limited partnership organized under the laws of Luxembourg;

 

10.       Advent International GPE VIII-B Limited Partnership, a limited partnership organized under the laws of Luxembourg;

 

11.       Advent International GPE VIII-C Limited Partnership, a limited partnership organized under the laws of Luxembourg;

 

12.       Advent International GPE VIII-D Limited Partnership, a limited partnership organized under the laws of Luxembourg;

 

13.       Advent International GPE VIII-F Limited Partnership, a limited partnership organized under the laws of Luxembourg;

 

14.       Advent International GPE VIII-H Limited Partnership, a limited partnership organized under the laws of Luxembourg;

 

15.       Advent International GPE VIII-I Limited Partnership, a limited partnership organized under the laws of Luxembourg;

 

16.       Advent International GPE VIII-J Limited Partnership, a limited partnership organized under the laws of Luxembourg;

 

17.       Advent Partners GPE VIII-A Limited Partnership, a Delaware limited partnership;

 

18.       Advent Partners GPE VIII-B Cayman Limited Partnership, a limited partnership organized under the laws of the Cayman Islands;

 

19.       Advent Partners GPE VIII Cayman Limited Partnership, a limited partnership organized under the laws of the Cayman Islands;

 

20.       Advent Partners GPE VIII-A Cayman Limited Partnership, a limited partnership organized under the laws of the Cayman Islands;

 

21.       Advent Partners GPE VIII Limited Partnership, a Delaware limited partnership;

 

22.       Advent International GPE VIII-A Limited Partnership, a limited partnership organized under the laws of the Cayman Islands;

 

23.       Advent International GPE VIII-E Limited Partnership, a limited partnership organized under the laws of the Cayman Islands;

 

24.       Advent International GPE VIII-G Limited Partnership, a limited partnership organized under the laws of the Cayman Islands;

 

25.       Advent International GPE VIII-K Limited Partnership, a limited partnership organized under the laws of the Cayman Islands;

 

26.       Advent International GPE VIII-L Limited Partnership, a limited partnership organized under the laws of the Cayman Islands;

 

27.       Culligan International Company, a Delaware corporation and an indirect subsidiary of Advent (“Culligan”); and

 

28.       Amberjack Merger Sub Limited, a business company incorporated under the laws of the British Virgin Islands and a wholly-owned subsidiary of Culligan (“Merger Subsidiary”).

 

The entities listed in subparagraphs (6) through (16) above are herein collectively referred to as “Advent Luxembourg Funds.” The entities listed in subparagraphs (17) through (21) above are herein collectively referred to as “Advent AP Funds.” The entities listed in subparagraphs (22) through (26) above are herein collectively referred to as “Advent Cayman Funds.” Advent, Advent Top GP, Advent GP Luxembourg, Advent GP AP, Advent GP Cayman, the Advent Luxembourg Funds, the Advent AP Funds and the Advent Cayman Funds are herein collectively referred to as the “Advent Reporting Persons.”

 

Advent is the manager of Advent Top GP, which in turn is the General Partner of each of Advent GP Luxembourg, Advent GP AP and Advent GP Cayman.

 

Advent GP Luxembourg is the General Partner of each of the Advent Luxembourg Funds. Advent GP AP is the General Partner of each of the Advent AP Funds. Advent GP Cayman is the General Partner of each of the Advent Cayman Funds.

 

31


 

The Advent Reporting Persons may be deemed to be the beneficial owner of the Shares held by the Stockholders by virtue of their ownership interest in Culligan.

 

The address of the principal business and the principal office of the Advent Reporting Persons is Prudential Tower, 800 Boylston Street, Boston, Massachusetts 02199-8069. Advent is one of the largest and most experienced global private equity firms. The address of the principal business and the principal office of each of Culligan and Merger Subsidiary is 9399 W. Higgins Rd, Ste 1100, Rosemont, Illinois 60018. Founded in 1936 by Emmett Culligan, Culligan is a world leader in delivering water solutions that will improve the lives of its customers.

 

The name, business address, present principal occupation or employment and citizenship of each director and executive officer (including a director and officer who may be a controlling person) of Advent, Culligan and Merger Subsidiary is set forth on Schedule A.

 

During the last five years, none of the Reporting Persons or, to the knowledge of the Reporting Persons, any of the persons listed on Schedule A attached hereto have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

Item 3.

Source and Amount of Funds or Other Consideration

 

The total amount of funds required by Culligan to consummate the Merger (as defined below) is approximately $1.1 billion, plus related fees and expenses. The Reporting Persons expect these payments to be funded using cash proceeds from equity and debt financing.

 

The information set forth or incorporated by reference in Item 4 is incorporated by reference in this Item 3.

 

Item 4.

Purpose of Transaction

 

As described in Item 3 above, this statement is being filed in connection with the Merger Agreement (as defined below) and the Voting Agreements (as defined below) (together with the Merger Agreement, the “Transaction Agreements”).

 

On December 23, 2019, the Issuer entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Culligan and Merger Subsidiary pursuant to which, subject to the satisfaction or waiver of the conditions therein, Merger Subsidiary will merge with and into the Issuer (the “Merger”), with the Issuer surviving as a wholly-owned subsidiary of Culligan. The Merger Agreement was unanimously approved by the members of the board of directors of the Issuer (the “Board”) and the Board resolved to recommend approval of the Merger Agreement to the Issuer’s shareholders.

 

Subject to the terms of the Merger Agreement, at the effective time of the Merger (the “Effective Time”), each ordinary share, of no par value per share, of the Issuer issued and outstanding immediately prior to the Effective Time (other than shares held by the Company in treasury, or owned by Culligan or Merger Subsidiary or held by stockholders who are entitled to dissent and who properly demand dissenter’s rights under BVI law) will be converted into, and thereafter only represent the right to receive $27.10 in cash, without interest (the “Merger Consideration”).

 

As an inducement to enter into the Merger Agreement, each of Doug Brown and Element Partners (collectively, the “Stockholders”), whom are both stockholders of the Issuer have entered into Voting Agreements with Culligan (the “Voting Agreements”), pursuant to which the Stockholders have agreed, among other things, to vote their respective Shares (as defined in the Merger Agreement) for the approval and adoption of the Merger Agreement and the approval of the Merger and the other transactions contemplated by the Merger Agreement. Based on the number of Shares of the Issuer as of November 4, 2019, the Stockholders signing Voting Agreements owned an aggregate of 35.50% of the outstanding Shares as of December 23, 2019.

 

32


 

The Stockholders have also agreed that they will vote their Shares against certain alternative corporate transactions, each as more fully described in the Voting Agreement, until the earliest to occur of (i) the effectiveness of the Merger, (ii) the date the Merger Agreement is validly terminated, (iii) the date that any (A) amendment or change to the Merger Agreement is effected without the Stockholder’s consent that decreases the Merger Consideration or changes the form or consideration payable under the Merger Agreement to the Stockholders or (B) any amendment or change to the Merger Agreement that is not approved by the Board is effected without the Stockholders’ consent that materially and adversely affects the Stockholders, or (iv) mutual written agreement of the Stockholders and Culligan.

 

Shared voting power with respect to the Shares owned by the Stockholders may be deemed to have been acquired through execution of the Voting Agreements. The Advent Reporting Persons may be deemed to be the beneficial owner of the Shares held by the Stockholders by virtue of their ownership interest in Culligan. The Reporting Persons have not expended any funds in connection with the execution of the Voting Agreements.

 

Schedule B attached hereto contains the names and number of Shares beneficially held by each Stockholder (as represented to Culligan by the Issuer and the Stockholders).

 

The purpose of the Merger is to acquire the control of, and, the entire equity interest in, the Issuer while allowing the Issuer’s stockholders an opportunity to receive the Merger Consideration. Culligan and Merger Subsidiary intend to consummate the Merger as promptly as practicable, subject to the satisfaction or waiver of certain conditions. At the effective time of the Merger, (i) the certificate of incorporation of the Issuer will be amended and restated in its entirety as set forth in an exhibit to the Merger Agreement, (ii) the bylaws of Merger Subsidiary, as in effect immediately prior to the effective time of the Merger, will be the bylaws of the Issuer and (iii) the directors and officers of Merger Subsidiary immediately prior to the effective time of the Merger will be the initial directors and officers of the Issuer.

 

Following the Merger, the Shares will no longer be traded on the New York Stock Exchange, there will be no public market for the Shares, and registration of the Shares under the Exchange Act will be terminated.

 

Except as set forth in this Statement and in connection with the Merger described above, the Reporting Persons do not have any plan or proposals that relate to or would result in any of the transactions described in Item 4 of this Schedule 13D.

 

The foregoing descriptions of the Merger Agreement and the Voting Agreements do not purport to be complete and are qualified in their entirety by reference to such agreements. A copy of the Merger Agreement is incorporated by reference to Exhibit 2.1 to the Issuer’s Current Report on Form 8-K filed with the Securities and Exchange Commission (“SEC”) on December 23, 2019. Copies of the Voting Agreements, which are attached as Exhibit 2.1 and 2.2 to this Schedule 13D, are incorporated herein by reference.

 

The Merger has not yet been consummated. The foregoing is neither an offer to purchase nor a solicitation of an offer to sell Shares.

 

Item 5.

Interest in Securities of the Issuer

 

(a) and (b) Other than those Shares that may be deemed to be beneficially owned in connection with the Transaction Agreements, the Reporting Persons have not acquired and, for the purposes of Rule 13d-4 promulgated under the Exchange Act, do not beneficially own any Shares.

 

As a result of the Transaction Agreements, the Reporting Persons may be deemed to have the power to vote up to an aggregate of 11,269,104 Shares against certain matters set forth in Item 4 above, and thus, for the purpose of Rule 13d-3 promulgated under the Exchange Act, the Reporting Persons may each be deemed to be the beneficial owner of the number of Shares corresponding to each Reporting Person as set forth above in this Schedule 13D. All Shares that may be deemed to be beneficially owned by the Reporting Persons constitute approximately 35.50% of the issued and outstanding Shares as of December 23, 2019 (as represented by the Issuer in the Merger Agreement).

 

33


 

The Reporting Persons are not entitled to any rights as stockholders of the Issuer as to the Shares covered by the Transaction Agreements, except as otherwise expressly provided in the Transaction Agreements.  This Schedule 13D shall not be construed as an admission by the Reporting Persons that the Reporting Persons are, for the purposes of Section 13(d) of the Securities Exchange Act of 1934, the beneficial owners of any ordinary shares of the Issuer covered by the Transaction Agreements.

 

Except as set forth in this Item 5(a), none of the Reporting Persons nor, to the knowledge of the Reporting Persons, any of the persons named in Schedule A hereto beneficially own any Shares.

 

(c) Except for the Transaction Agreements described above, to the knowledge of the Reporting Persons, no transactions in the class of securities reported have been effected during the past 60 days by any person named in Schedule A or Item 5(a).

 

(d) To the knowledge of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities of the Issuer reported herein.

 

(e) Inapplicable.

 

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

 

Except for the Transaction Agreements described above, to the knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise), including, but not limited to, transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies, among the persons named in Item 2 or between such persons and any other person, with respect to any securities of Issuer, including any securities pledged or otherwise subject to a contingency the occurrence of which would give another person voting power or investment power over such securities.

 

Item 7.

Material to Be Filed as Exhibits

 

 2.1

 

Voting Agreement, dated as of December 23, 2019, by and between Culligan International Company and Element Partners II L.P., Element II-A, L.P., Element Partners II Intrafund, L.P., DJF Element, L.P. and DJF Element Intrafund, L.P.*

 2.2

 

Voting Agreement, dated as of December 23, 2019, by and between Culligan International Company and Doug Brown*

99.1

 

Joint Filing Agreement, dated as of January 2, 2020, by and among Culligan International Company and Amberjack Merger Sub Limited*

 


*  Filed herewith.

 

34


 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

Date: January 2, 2020

 

ADVENT INTERNATIONAL CORPORATION

 

 

 

 

 

/s/ James Westra

 

 

Name:

James Westra

 

 

Title:

General Counsel and Managing Partner

 

 

 

 

Date: January 2, 2020

 

CULLIGAN INTERNATIONAL COMPANY

 

 

 

 

 

 

/s/ Frank John Griffith

 

 

Name:

Frank John Griffith

 

 

Title:

Vice President and General Counsel

 

 

 

 

Date: January 2, 2020

 

AMBERJACK MERGER SUB LIMITED

 

 

 

 

 

 

/s/ Samuel Allen Hamood

 

 

Name:

Samuel Allen Hamood

 

 

Title:

Sole Director

 

 

 

 

Date: January 2, 2020

 

 

 

 

ADVENT INTERNATIONAL GPE VIII LIMITED PARTNERSHIP
ADVENT INTERNATIONAL GPE VIII-B-1 LIMITED PARTNERSHIP
ADVENT INTERNATIONAL GPE VIII-B-2 LIMITED PARTNERSHIP
ADVENT INTERNATIONAL GPE VIII-B-3 LIMITED PARTNERSHIP
ADVENT INTERNATIONAL GPE VIII-B LIMITED PARTNERSHIP
ADVENT INTERNATIONAL GPE VIII-C LIMITED PARTNERSHIP
ADVENT INTERNATIONAL GPE VIII-D LIMITED PARTNERSHIP
ADVENT INTERNATIONAL GPE VIII-F LIMITED PARTNERSHIP
ADVENT INTERNATIONAL GPE VIII-H LIMITED PARTNERSHIP
ADVENT INTERNATIONAL GPE VIII-I LIMITED PARTNERSHIP
ADVENT INTERNATIONAL GPE VIII-J LIMITED PARTNERSHIP

 

By: GPE VIII GP S.À R.L., GENERAL PARTNER
By: ADVENT INTERNATIONAL GPE VIII, LLC, MANAGER

 

 

 

 

 

/s/ Justin Nuccio

 

 

Justin Nuccio, Manager

 

 

 

 

 

By: ADVENT INTERNATIONAL CORPORATION, MANAGER

 

 

 

 

 

 

/s/ James Westra

 

 

Name:

James Westra

 

 

Title:

General Counsel and Managing Partner

 

35


 

Date: January 2, 2020

 

 

 

 

ADVENT PARTNERS GPE VIII-A LIMITED PARTNERSHIP

ADVENT PARTNERS GPE VIII-B CAYMAN LIMITED PARTNERSHIP

ADVENT PARTNERS VIII CAYMAN LIMITED PARTNERSHIP

ADVENT PARTNERS GPE VIII-A CAYMAN LIMITED PARTNERSHIP

ADVENT PARTNERS GPE VIII LIMITED PARTNERSHIP

 

By: AP GPE VIII GP LIMITED PARTNERSHIP, GENERAL PARTNER

By: ADVENT INTERNATIONAL GPE VIII, LLC, GENERAL PARTNER

By: ADVENT INTERNATIONAL CORPORATION, MANAGER

 

 

 

 

 

/s/ James Westra

 

 

Name:

James Westra

 

 

Title:

General Counsel and Managing Partner

 

 

 

Date: January 2, 2020

 

ADVENT INTERNATIONAL GPE VIII-A LIMITED PARTNERSHIP

ADVENT INTERNATIONAL GPE VIII-E LIMITED PARTNERSHIP

ADVENT INTERNATIONAL GPE VIII-G LIMITED PARTNERSHIP

ADVENT INTERNATIONAL GPE VIII-K LIMITED PARTNERSHIP

ADVENT INTERNATIONAL GPE VIII-L LIMITED PARTNERSHIP

 

By: GPE VIII GP LIMITED PARTNERSHIP, GENERAL PARTNER

By: ADVENT INTERNATIONAL GPE VIII, LLC, GENERAL PARTNER

By: ADVENT INTERNATIONAL CORPORATION, MANAGER

 

 

 

 

 

/s/ James Westra

 

 

Name:

James Westra

 

 

Title:

General Counsel and Managing Partner

Date: January 2, 2020

 

 

 

 

 

GPE VIII S.À R.L.

 

 

By: ADVENT INTERNATIONAL GPE VIII, LLC, MANAGER

 

 

 

 

 

/s/ Justin Nuccio

 

 

Justin Nuccio, Manager

 

 

 

 

 

By: ADVENT INTERNATIONAL CORPORATION, MANAGER

 

 

 

 

 

/s/ James Westra

 

 

Name:

James Westra

 

 

Title:

General Counsel and Managing Partner

 

36


 

Date: January 2, 2020

 

AP GPE VIII GP LIMITED PARTNERSHIP

 

 

 

 

 

By: ADVENT INTERNATIONAL GPE VIII, LLC, GENERAL PARTNER

By: ADVENT INTERNATIONAL CORPORATION, MANAGER

 

 

 

 

 

/s/ James Westra

 

 

Name:

James Westra

 

 

Title:

General Counsel and Managing Partner

 

 

 

 

Date: January 2, 2020

 

GPE VIII GP LIMITED PARTNERSHIP

 

 

 

 

 

By: ADVENT INTERNATIONAL GPE VIII, LLC, GENERAL PARTNER

By: ADVENT INTERNATIONAL CORPORATION, MANAGER

 

 

 

 

 

/s/ James Westra

 

 

Name:

James Westra

 

 

Title:

General Counsel and Managing Partner

 

 

 

 

Date: January 2, 2020

 

ADVENT INTERNATIONAL GPE VIII, LLC

 

 

 

 

 

By: ADVENT INTERNATIONAL CORPORATION, MANAGER

 

 

 

 

 

/s/ James Westra

 

 

Name:

James Westra

 

 

Title:

General Counsel and Managing Partner

 

37


 

SCHEDULE A

 

1.

Advent International Corporation

 

The name, business address, title, present principal occupation or employment of each of the directors and executive officers of Advent International Corporation (“Advent”), are set forth below. If no business address is given, the director’s or executive officer’s business address is Prudential Tower, 800 Boylston Street, Boston, Massachusetts 02199-8069. Unless otherwise indicated, each occupation set forth opposite an individual’s name refers to Advent. Unless otherwise indicated below, all of the persons listed below are citizens of the United States of America.

 

Name

 

Position with Advent
International Corporation

 

Principal Occupation
(if different)

Peter A. Brooke

 

Director, Chairman Emeritus

 

 

Thomas H. Lauer

 

Director

 

 

Richard F. Kane

 

Senior Vice President of Operations and Business Development & Managing Director; Assistant Secretary

 

 

Eileen Sivolella

 

Senior Vice President & Managing Director; Chief Financial Officer; Treasurer; Assistant Secretary

 

 

James R. Westra

 

Senior Vice President & Managing Partner; Chief Legal Officer; General Counsel

 

 

Andrew D. Dodge

 

Vice President; Deputy General Counsel; Secretary

 

 

Heather R. Zuzenak

 

Chief Compliance Officer

 

 

Jarlyth H. Gibson

 

Risk Officer; Assistant Treasurer

 

 

James G.A. Brocklebank

 

Senior Vice President & Managing Partner; Executive Officers’ Committee Member

 

 

Patrice Etlin

 

Senior Vice President & Managing Partner; Executive Officers’ Committee Member

 

 

Jan Janshen

 

Senior Vice President & Managing Partner; Executive Officers’ Committee Member

 

 

David M. Mussafer

 

Director; Chairman & Managing Partner; Executive Officers’ Committee Member

 

 

David M. McKenna

 

Director; Senior Vice President & Managing Partner; Executive Officers’ Committee Member

 

 

Steven M. Tadler

 

Director

 

 

John F. Brooke

 

Director

 

Managing Director of Brooke Private Equity Associates (1)

Mark Hoffman

 

Director

 

 

 

38


 

2.

Culligan International Company

 

The name, business address, title, present principal occupation or employment of each of the directors and executive officers of Culligan International Company (“Culligan”), are set forth below. If no business address is given, the director’s or executive officer’s business address is 9399 W. Higgins Rd, Ste 1100, Rosemont, IL 60018. Unless otherwise indicated, each occupation set forth opposite an individual’s name refers to Culligan. Unless otherwise indicated below, all of the persons listed below are citizens of the United States of America.

 

Name

 

Present Principal Occupation Including Name and Address of Employer

Directors

 

 

 

 

 

Scott G. Clawson

 

President and Chief Executive Officer and Director

 

 

 

Judd H. Larned

 

President, North America and Director

 

 

 

Samuel Allen Hamood

 

Senior Vice President, Chief Financial Officer, Treasurer and Director

 

Name

 

Present Principal Occupation Including Name and Address of Employer

Executive Officers (Who Are Not Directors)

 

 

 

 

 

Gary Parkinson

 

Senior Vice President and Chief Human Resources Officer

 

 

 

Brandt McKee

 

President, Americas

 

 

 

Lawrence S. Holzman

 

Senior Vice President

 

 

 

Ramona Cibas

 

Vice President and Controller

 

 

 

Frank John Griffith

 

Vice President, General Counsel & Secretary

 

 

 

Braulio Sanchez

 

Vice President of Tax

 

 

 

Andrew Kellogg

 

Vice President of Treasury

 

39


 

3.

Amberjack Merger Sub Limited

 

The name, business address, title, present principal occupation or employment of each of the directors and executive officers of Amberjack Merger Sub Limited (“Merger Subsidiary”) are set forth below. If no business address is given, the director’s or executive officer’s business address is 9399 W. Higgins Rd, Ste 1100, Rosemont, IL 60018. Unless otherwise indicated, each occupation set forth opposite an individual’s name refers to Merger Subsidiary. Unless otherwise indicated below, all of the persons listed below are citizens of the United States of America.

 

Name

 

Present Principal Occupation Including Name and Address of Employer

 

 

 

Directors

 

 

 

 

 

Samuel Allen Hamood

 

Sole Director

 

Name

 

Present Principal Occupation Including Name and Address of Employer

 

 

 

Executive Officers (Who Are Not Directors)

 

 

 

 

 

N/A

 

 

 

40


 

SCHEDULE B

 

Stockholder

 

Shares Beneficially Owned (1)

 

Element Partners

 

9,568,818

 

Doug Brown

 

1,700,286

 

 


(1)     As of November 4, 2019, as provided by the Issuer.

 

41


AquaVenture (NYSE:WAAS)
Historical Stock Chart

1 Year : From Mar 2019 to Mar 2020

Click Here for more AquaVenture Charts.

AquaVenture (NYSE:WAAS)
Intraday Stock Chart

Today : Saturday 28 March 2020

Click Here for more AquaVenture Charts.

Latest WAAS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
$
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200328 16:01:59